The Pan African Society of Cardiology presents the third edition of AfricaSTEMI LIVE! 2018 and launching of the brand new Heart of Africa meeting from the 26th – 28th April 2018 at The Radisson Blu Hotel, Nairobi, Kenya
This year’s meeting will introduce the ‘Heart of Africa’ meeting, which aims to broaden the discussion beyond acute coronary syndromes and take a focused approach to unique African challenges in cardiovascular disease. This inaugural event will run simultaneously with AfricaSTEMI Live! with a focus on “Heart Failure in Africa”, giving attendees an opportunity to customize their educational experience.
AFRICA STEMI LIVE! 2018
Africa Stemi Live! 2018 is the centerpiece conference in cardiovascular medicine focusing on the management of heart attacks given our unique challenges of the African continent. This meeting strives to engage all key healthcare professionals involved in the prevention and treatment of patients with acute coronary syndromes.
Last year more than 380 healthcare practitioners came together to network, learn and share strategies to prepare for the growing burden of heart attacks that the continent is facing. The multi-disciplinary program is designed with relevant lectures, workshops and mini-courses relevant to doctors, nurses, emergency health personnel, government health workers as well as medical insurance companies.
Leading local and International experts will comprise a stellar faculty that will take participants through state-of-the-art STEMI management. The latest guidelines will be discussed in the African context and participants will have several opportunities for knowledge and experience sharing throughout the meeting. The meeting will maintain its interactive nature through live case presentations, patient interviews, panel discussions and breakaway workshops designed to cater for all levels of delegates.
Insurance Company Executives
Ministry of Health
REGISTRATION FEEInternational delegates USD 250*
African Delegates USD 135*
Concession USD 80*
SPONSORSHIP OPPORTUNITYTake advantage of early bird registration and pay only 95 USD of your registration before 1st April 2018.
Prof. Christopher GrangerProfessor of Medicine at Duke University Medical Center
Prof. Christopher B. Granger, MD is Professor of Medicine at Duke University Medical Center. He has published more than 500 papers including the Landmark Aristotle trial. He is an authority in systems of care in STEMI, out of hospital cardiac arrest, and atrial fibrillation/anticoagulation and is an expert on design and interpretation of randomized controlled trials.
Prof. Thomas LuscherChairman of Cardiology at the University Hospital Zurich
Prof. Thomas F. Lüscher is a Professor and Chairman of Cardiology at the University Hospital Zurich and Director of CardioVascular Research at the Institute of Physiology of the University of Zurich, Switzerland. He is Editor-in-chief of the European Heart Journal and he has published hundreds of original research articles and review articles. He is a board certified internist and cardiologist with training in internal medicine at the University Hospital Zurich, cardiovascular physiology and cardiology at the Mayo Clinic, Rochester, Minn., USA and in cardiology and clinical pharmacology at the University Hospital Basel, Switzerland. Prior to this, he was Professor of Pharmacotherapy at the University of Basel, then Professor and vice-chairman of cardiology at the Inselspital of the University of Berne, Switzerland.
Prof. Bongani MayosiDean of the Faculty of Health Sciences at the University of Cape Town
Prof. Bongani Mayosi is the Dean of the Faculty of Health Sciences at the University of Cape Town. He is also a Chief Specialist at Groote Schuur Hospital in Cape Town. Mayosi is ex-officio President of the Panafrican Society of Cardiology and is a former the President of the South African Heart Association and of the South African College of Physicians.
Dr. David KettlesCardiologist
David Kettles, is a cardiologist working predominantly in private practice in East London, South Africa.
After completing his undergraduate and postgraduate internal medicine studies at the University of Cape Town, he spent additional training time in Brighton UK, before returning to East London to open an interventional cardiac facility, the first in the region.
He immediately commenced a primary PCI programme for all STEMI patients at the private hospitals in the city, and since presenting the results of primary PCI in his hospital at the SA Heart association meetings, has developed STEMI management as a primary interest.
He is president of the South African Society for Cardiovascular Intervention (SASCI), and on the national STEMI committee, striving to improve the outcomes for STEMI patients treated in South Africa.
Dr. Jonathan ByrneClinical Director of Cardiovascular services at King’s College Hospital
Dr Byrne is the Clinical Director of Cardiovascular services at King’s College Hospital. He completed his undergraduate medical training in Bristol and then continued general professional medical training in the South-East of England and London. A PhD in the academic department of Cardiology at King’s College Hospital was awarded in 2004; this examined the molecular mechanisms underlying left ventricular hypertrophy.
His training in interventional cardiology was undertaken at King’s College Hospital from 2004, and continued on Vancouver Island, Canada. He was appointed as a consultant in 2008. As well as percutaneous coronary intervention, his clinical interests also include transoesophageal echocardiography and cardiac CT. He has also been involved in the development of the structural programme at Kings College Hospital, with the use of novel percutaneous techniques to treat aortic (TAVI) and mitral valve disease. His research interests have included the molecular mechanisms which underlie the development of left ventricular hypertrophy, and the application of coronary physiology in an interventional setting. His research has also explored the differences and potential advantages of intervention performed form the radial artery.
Dr. Bernard GershProfessor of Medicine at Mayo Clinic College of Medicine
Professor of Medicine at Mayo Clinic College of Medicine, Consultant in Cardiovascular Diseases and Internal Medicine. His past positions include The W. Proctor Harvey Teaching Professor of Cardiology and Chief of the Division of Cardiology at Georgetown University Medical Center. Dr. Gersh received his MB, ChB, from the University of Cape Town in South Africa. He received his Doctor of Philosophy Degree from Oxford University where he was a Rhodes Scholar.
Dr. Gersh’s wide interests include the natural history and therapy of acute and chronic coronary artery disease, clinical electrophysiology and in particular atrial fibrillation, sudden cardiac death and syncope, cardiac stem cell therapy, and the epidemiology of cardiovascular disease in the developing world. He has published 819 manuscripts and 141 book chapters. (h-index 106) Dr. Gersh is the editor of 14 books and is on the editorial board of 25 journals including Circulation, Journal of the American College of Cardiology, Nature Cardiovascular Medicine, and The European Heart Journal (Deputy Editor) He is also Editor-in-Chief of UpToDate in Cardiology. He was a member of the Advisory Board of the Reynolds Foundation, a Past Chairman of the Council of Clinical Cardiology of the American Heart Association, a member of the World Heart Federation’s Scientific and Policy Initiatives Committee (SPIC), and a former Member of the Board of Trustees of the American College of Cardiology. He has served on the Steering Committees and Data Safety Monitoring Boards of multiple clinical trials, sponsored by the National Lung and Blood Institute and other organizations. Dr. Gersh is a member of the Advisory Board of the Hatter Cardiovascular Research Institute, University of Cape Town. He is currently Chairman of the WHO Cardiovascular Working Group on ICD 11 Reclassification. Dr. Gersh is a member of the Association of University Cardiologists and a member of Medscape Business of Medicine.
Dr. Gersh’s honors include Teacher of the Year Award from the Division of Cardiovascular Diseases, Mayo Clinic and numerous Visiting Professorships and Invited Lectures both nationally and internationally including the 2009 Henry Russek ACC lecture, Rene Laennec Invited Lecture and Silver Medal of the ESC (2010),the William McDonald lectureship to the Heart and Stroke Foundation of Canada, the Silberberg Memorial Lecture at the Cardiac Society of Australia and New Zealand, the Criscitiello Visiting Professor Lecture at Tufts Medical Center, the Thomas W. Smith Lecture at Brigham and Women’s Hospital, and the Hatter Award for “Advancement in the Cardiovascular Science” from the University College London and the University of Cape Town, the Max Holzman Lecture at the University of Zurich, and at ESC in 2013 he was designated as one of four “legends of modern cardiology”. He is an Honorary Member/Fellow of the South African Cardiac Society and the South African Heart Association, the Sociedad Chilena De Cardiologia Y Cirugia Cardiovascular, the Cardiac Society of India, and the British Cardiac Society. He is an Honorary Professor of Medicine at the University of Cape Town, South Africa, and an Adjunct Professor in the Department of Medicine at Duke University School of Medicine. In 2014 he was named in the Thomson Reuters list of individuals with the greatest number of cited scientific papers 2002-2012.
Dr. Gersh was the 2004 recipient of the Distinguished Achievement Award of the AHA Council of Clinical Cardiology and the 2007 recipient of the ACC Distinguished Service Award. He received the degree of Ph.D. (honoris causa) from The University of Coimbra, Portugal in 2005. Dr. Gersh is the recipient of the 2012 James B. Herrick award of the AHA and in 2013 he was designated Master of the American College of Cardiology.
Dr. Thomas AlexanderHead of the Division of Cardiology at Kovai Medical Center
Dr. Thomas Alexander, MD, DM, FACC, FICC, FCSI is an Interventional Cardiologist who is the Head of the Division of Cardiology at Kovai Medical Center and Hospital in Coimbatore, India. Dr. Alexander has established a very active interventional unit at the hospital, which performs 1,500 procedures per year, including 500 cardiac and 150 peripheral interventions.
Dr. Alexander is the Course Director of the STEMI India meeting, an international STEMI conference and the only one of its type in India. He serves as a Member of India Editorial Advisory Board at mdCurrent, LLC. He is also the founder trustee of STEMI- INDIA, a not-for- profit organization that disseminates information on STEMI management, trains STEMI teams, and develops national STEMI guidelines and develops a STEMI system of care in India. Dr. Alexander is a member of the National Guideline Committee, established by the Union Health Ministry, has served in leadership positions for several cardiology societies in India.
He has presented papers and given lectures at numerous regional, national, and international meetings and has been invited faculty at major cardiology and interventional cardiology conferences. Dr. Alexander is active as a principal investigator in numerous cardiology-focused clinical trials.
Dr Ahmed SulimanAssociate Professor of Cardiology, Faculty of Medicine University of Khartoum and an Interventional Cardiologist
Dr Ahmed Suliman is an Associate Professor of Cardiology, Faculty of Medicine University of Khartoum and an Interventional Cardiologist, at the National Cardiothoracic Center at Al Shab Teaching Hospital. Khartoum, Sudan. He is the Coordinator of Sudan Medical Specialization Board Cardiology Fellowship program. He is a former Secretary General for Sudan Heart society ( February 2012- February 2014) and is a current Fellow of the European Society of Cardiology and of the American College of Physicians . In addition, Dr Suliman is a co-Director of Africa PCR.
He undertook training in Interventional Cardiology Fellowship at St Vincent’s University Hospital after completing his General Cardiology Training at Sudan Heart Center 2002-2005 and Internal Medicine Fellowship at Mount Sinai School of Medicine Program at Elmhurst Hospital, New York.
Dr. Tom MabinMB ChB; BSc (Hons)(Birm.) FACC; FESC; FRCP Cardiologist
Experienced clinical cardiologist and pioneer in the interventional cardiology practice in South Africa. Additional interest in complex pacemaker implants. Recently has pioneered Transcutaneous Aortic Valve Implantation(TAVI) in South Africa and currently one of the most experienced operators in this field.
Passion for post-graduate education in various roles and Director of Crossroads Institute (South Africa) and convenor of a number of national/international cardiology congresses. Frequent Faculty Member of International Interventional Cardiology Programs including EuroPCR and TCT. Member of the Scientific Advisory Board of EuroPCR.
Founding Chairman of South African Society of Cardiovascular Intervention (SASCI).
Fellow of the Royal College of Physicians, American College of Cardiology and European Society of Cardiology
Prof. Martin CowieProfessor of Cardiology at the National Heart and Lung Institute, imperial College London
Professor Cowie is Professor of Cardiology at the National Heart and Lung Institute, imperial College London. He was a founder member of the British Society of Heart Failure, and was President of that professional organization. He is a recognized world expert on heart failure and sleep disordered breathing in HF. He is engaged in advisory groups such as NICE, NHS England and is on the working group for guidelines and technology appraisals. He is chair of the Breathlessness Project London, under the auspices of the CLAHRC programme.
Dr.Harun OtienoAfrica Heart Associates
Africa Heart Associates, specialises in providing comprehensive, evidence-based, compassionate care to patients with heart & vascular diseases. Our offices are located at Room 201, Doctors Plaza at The Aga Khan University Hospital, Nairobi. We provide in-patient care at other hospitals including The Nairobi Hospital, The Mater Hospital and MP Shah Hospital to cater for the wide spectrum of patients presenting with heart related diseases. We are available for minimally invasive heart procedures and provide top quality emergency cardiac care.
Dr. Otieno worked in Texas, USA prior to returning to Kenya in late 2008. A graduate of the University of Nairobi, he completed his medical school training in 1995. He received his postgraduate medical training in Internal Medicine, General Cardiology and Interventional Cardiology in Pittsburgh, Pennsylvania, USA completing his training in 2006. He has full Board Certification by the (ABIM) American Board of Internal Medicine in Internal Medicine in Cardiovascular Diseases, Interventional Cardiology and Nuclear Cardiology and is a Fellow of the American College of Cardiology. The Kenya Medical Practitioners Board has granted him Specialist Recognition status in Cardiology/Internal Medicine.
A highly sought speaker and excellent clinical educator, Dr. Otieno is involved in professional medical education of his peers as well Residents in training. He is also passionate about improving health outcomes in the region and has been involved in Health Tourism, Medical Conferencing, Promoting wellness and prevention of lifestyle diseases, organising medical missions as well as promoting regionally relevant research.
Dr. Emmy OkelloCardiologist
Is an interventional cardiologist at the Uganda Heart Institute. He performs percutaneous mitral commissurotomy for patients with severe mitral stenosis. He completed his PhD training at Makerere University in 2015. His research was on the burden, risk factors and outcome of rheumatic heart disease (RHD) in Uganda. His findings showed that there is big burden of RHD in Uganda which is associated with high morbidity and mortality.
He also found genetic susceptibility to RHD related to the major histocompatibility complex (MHC) class II Human Leucocyte Antigens(HLA)- DR 11.As a THRIVE postdoctoral Fellow, Dr. Okello will look at the epidemiology and pathogenesis of acute rheumatic fever in Lira District, Northern Uganda, based on the problem that very few cases of ARF are currently being diagnosed reported, to explain the very prevalent cases of clinical rheumatic heart disease seen in hospitals around the country.
This study is expected to improve the diagnosis of acute rheumatic fever diagnosis and contribute to the reduction of morbidity and mortality associated with RHD, the long term consequence of rheumatic fever.His PhD work enabled him to join international research groups on rheumatic heart disease and rheumatic fever. He is mentored by Professor James Tumwine (Makerere), Dr. Andrea Beaton (Washington), Dr. Tom Parks (LSHTM) and Professor Jonathan Carapetis (Australia).
SYSTEMS OF CARE
What is different about STEMI in Africa Managing STEMI in a peripheral hospital. What we do. Strategies to reduce patient delays. Time to each event point. Practical strategies to risk stratify STEMI patients. Only one place in the ambulance. Who do we send for PCI?
WHAT IS NEW IN STEMI 2018
Studies that have impacted STEMI management in 2017 ESC STEMI guidelines 2017 Cardiogenic shock in 2018 - contemporary management. Toys and gadgets. What we have done since AfricaSTEMI 2017 Radial or Femoral. Is this even a question?
STEMI IN THE CATHLAB
Stent technology in 2018 Thrombus aspiration is still relevant Slow flow - new tips and tricks from an old hand STEMI in patients who have already been revascularised. Stent thrombosis and graft occlusion The late presenter with angina and an LV thrombus. PCI in a patient who needs anticoagulants and antiplatelets STEMI without atherosclerosis. What we can learn from intravascular imaging. STEMI cases from around Africa.
STEMI IN THE EMERGENCY ROOM
How to store and prepare thrombolytics Lytic agent. Which one should I stock? New antiplatelet agents. Which one should I stock? My late presenting patient is hypotensive but I want to prevent adverse remodelling and avoid cardiogenic shock Automated External Defibrillators are easy Standard defibrillators are easy How many AEDs do we need and where should we put them?
MASTERING DIAGNOSIS OF STEMI
ECGs in STEMI - the easy cases ECGs in STEMI. LVH, RBBB and pre-excitation. ECGs in STEMI - echo as a referee Biomarkers for STEMI - which is the fastest, most sensitive, nost available and most specific assay? Unusual clinical presentation for STEMI pattern recognition Failed fibrinolysis. Recognition and management
We wish to immensely thank these amazing guys for supporting us in hosting this conference Interested in becoming a sponsor? Get in touch